0001415889-24-003581.txt : 20240213
0001415889-24-003581.hdr.sgml : 20240213
20240213173025
ACCESSION NUMBER: 0001415889-24-003581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simmons Jeffrey N
CENTRAL INDEX KEY: 0001479079
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 24630265
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
form4-02132024_100208.xml
X0508
4
2024-02-09
0001739104
Elanco Animal Health Inc
ELAN
0001479079
Simmons Jeffrey N
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
true
true
false
false
PRESIDENT, CEO AND DIRECTOR
0
Deferred Stock Units
2024-02-09
4
A
0
173.4026
15.97
A
Common Stock
173.4026
533.9157
D
Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
/s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons
2024-02-13